What is the ticker symbol for CureVac N.V.?

CureVac N.V. trades under the ticker CVAC on NASDAQ.

What sector does CureVac N.V. operate in?

CureVac N.V. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CVAC in a portfolio?

PortView shows CVAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

CureVac N.V. (CVAC) Stock Analysis

NASDAQHealthcareBiotechnology

$4.66+0.00%

1-year price historyRange $2.59 – $5.60

52-week range$4.66

$2.48$5.72

What CureVac N.V. does

CureVac N.V. is a biopharmaceutical company currently in the clinical stage, specializing in creating innovative medical treatments leveraging messenger ribonucleic acid (mRNA) technology. Its portfolio encompasses various mRNA-based prophylactic vaccines. Among these is CV2CoV, an mRNA vaccine candidate addressing SARS-CoV-2, presently in Phase 1 clinical investigation. Another key candidate, CV7202, an mRNA prophylactic targeting the rabies virus glycoprotein, has successfully completed its Phase 1 clinical evaluation. Additionally, CVSQIV, aimed at influenza, is also undergoing Phase 1 clinical trials. Further vaccine development efforts are directed towards lassa fever, yellow fever, respiratory syncytial virus, rotavirus, malaria, and a universal influenza solution. Beyond its vaccine initiatives, CureVac is also engaged in developing RNA-based immunotherapies for cancer. For instance, CV8102, an immunotherapy, is currently undergoing Phase 1 trials for the treatment of cutaneous melanoma, adenoidcystic carcinoma, and squamous cell carcinoma affecting the skin, head, and neck. The company was established in 2000 and operates from its main office in Tübingen, Germany.

Key metrics

Market cap

$1.05B

P/E (TTM)

6.96

EPS (TTM)

$0.67

Beta

1.84

Dividend yield

0.00%

Revenue / share

$0.25

50-day avg

$4.97

200-day avg

$4.85

52-week high

$5.72

52-week low

$2.48

CEO

Alexander Zehnder

ETFs linked to CVAC

Broad-market and Healthcare sector ETFs an investor holding CureVac N.V. is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CVAC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CVAC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for CureVac N.V.?: CureVac N.V. trades under the ticker CVAC on NASDAQ.
Which exchange is CVAC listed on?: CVAC is listed on NASDAQ.
What sector does CureVac N.V. operate in?: CureVac N.V. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CVAC in a portfolio?: PortView shows CVAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.